Latest News

• 25 Mar 2019
  Oncostellae participates at the BIO-Europe partnering conference in Vienna
  
  
• 10 Dec 2018
  GI-restricted Jak3/Tyk2 inhibitor OST-122 well tolerated in clinical phase Ia study
  
  
• 23 Jul 2018
  Oncostellae initiated clinical development of OST-122